Protection and polyfunctional T cells induced by Ag85B-TB10.4/IC31 against Mycobacterium tuberculosis is highly dependent on the antigen dose.

BACKGROUND:Previously we have shown that Ag85B-TB10.4 is a highly efficient vaccine against tuberculosis when delivered in a Th1 inducing adjuvant based on cationic liposomes. Another Th1 inducing adjuvant, which has shown a very promising profile in both preclinical and clinical trials, is IC31. In...

Full description

Bibliographic Details
Main Authors: Claus Aagaard, Truc Thi Kim Thanh Hoang, Angelo Izzo, Rolf Billeskov, JoLynn Troudt, Kim Arnett, Andrew Keyser, Tara Elvang, Peter Andersen, Jes Dietrich
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2009-06-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC2691953?pdf=render
_version_ 1818386765248987136
author Claus Aagaard
Truc Thi Kim Thanh Hoang
Angelo Izzo
Rolf Billeskov
JoLynn Troudt
Kim Arnett
Andrew Keyser
Tara Elvang
Peter Andersen
Jes Dietrich
author_facet Claus Aagaard
Truc Thi Kim Thanh Hoang
Angelo Izzo
Rolf Billeskov
JoLynn Troudt
Kim Arnett
Andrew Keyser
Tara Elvang
Peter Andersen
Jes Dietrich
author_sort Claus Aagaard
collection DOAJ
description BACKGROUND:Previously we have shown that Ag85B-TB10.4 is a highly efficient vaccine against tuberculosis when delivered in a Th1 inducing adjuvant based on cationic liposomes. Another Th1 inducing adjuvant, which has shown a very promising profile in both preclinical and clinical trials, is IC31. In this study, we examined the potential of Ag85B-TB10.4 delivered in the adjuvant IC31 for the ability to induce protection against infection with Mycobacterium tuberculosis. In addition, we examined if the antigen dose could influence the phenotype of the induced T cells. METHODS AND FINDINGS:We found that vaccination with the combination of Ag85B-TB10.4 and IC31 resulted in high numbers of polyfunctional CD4 T cells co-expressing IL-2, IFN-gamma and TNF-alpha. This correlated with protection against subsequent challenge with M.tb in the mouse TB model. Importantly, our results also showed that both the vaccine induced T cell response, and the protective efficacy, was highly dependent on the antigen dose. Thus, whereas antigen doses of 5 and 15 microg did not induce significant protection against M.tb, reducing the dose to 0.5 microg selectively increased the number of polyfunctional T cells and induced a strong protection against infection with M.tb. The influence of antigen dose was also observed in the guinea pig model of aerosol infection with M.tb. In this model a 2.5 fold increase in the antigen dose reduced the protection against infection with M.tb to the level observed in non-vaccinated animals. CONCLUSIONS/SIGNIFICANCE:Small changes in the antigen dose can greatly influence the induction of specific T cell subpopulations and the dose is therefore a crucial factor when testing new vaccines. However, the adjuvant IC31 can, with the optimal dose of Ag85B-TB10.4, induce strong protection against Mycobacterium tuberculosis. This vaccine has now entered clinical trials.
first_indexed 2024-12-14T03:59:15Z
format Article
id doaj.art-73337be1b5dd4c63aea3644c43069708
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-14T03:59:15Z
publishDate 2009-06-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-73337be1b5dd4c63aea3644c430697082022-12-21T23:18:00ZengPublic Library of Science (PLoS)PLoS ONE1932-62032009-06-0146e593010.1371/journal.pone.0005930Protection and polyfunctional T cells induced by Ag85B-TB10.4/IC31 against Mycobacterium tuberculosis is highly dependent on the antigen dose.Claus AagaardTruc Thi Kim Thanh HoangAngelo IzzoRolf BilleskovJoLynn TroudtKim ArnettAndrew KeyserTara ElvangPeter AndersenJes DietrichBACKGROUND:Previously we have shown that Ag85B-TB10.4 is a highly efficient vaccine against tuberculosis when delivered in a Th1 inducing adjuvant based on cationic liposomes. Another Th1 inducing adjuvant, which has shown a very promising profile in both preclinical and clinical trials, is IC31. In this study, we examined the potential of Ag85B-TB10.4 delivered in the adjuvant IC31 for the ability to induce protection against infection with Mycobacterium tuberculosis. In addition, we examined if the antigen dose could influence the phenotype of the induced T cells. METHODS AND FINDINGS:We found that vaccination with the combination of Ag85B-TB10.4 and IC31 resulted in high numbers of polyfunctional CD4 T cells co-expressing IL-2, IFN-gamma and TNF-alpha. This correlated with protection against subsequent challenge with M.tb in the mouse TB model. Importantly, our results also showed that both the vaccine induced T cell response, and the protective efficacy, was highly dependent on the antigen dose. Thus, whereas antigen doses of 5 and 15 microg did not induce significant protection against M.tb, reducing the dose to 0.5 microg selectively increased the number of polyfunctional T cells and induced a strong protection against infection with M.tb. The influence of antigen dose was also observed in the guinea pig model of aerosol infection with M.tb. In this model a 2.5 fold increase in the antigen dose reduced the protection against infection with M.tb to the level observed in non-vaccinated animals. CONCLUSIONS/SIGNIFICANCE:Small changes in the antigen dose can greatly influence the induction of specific T cell subpopulations and the dose is therefore a crucial factor when testing new vaccines. However, the adjuvant IC31 can, with the optimal dose of Ag85B-TB10.4, induce strong protection against Mycobacterium tuberculosis. This vaccine has now entered clinical trials.http://europepmc.org/articles/PMC2691953?pdf=render
spellingShingle Claus Aagaard
Truc Thi Kim Thanh Hoang
Angelo Izzo
Rolf Billeskov
JoLynn Troudt
Kim Arnett
Andrew Keyser
Tara Elvang
Peter Andersen
Jes Dietrich
Protection and polyfunctional T cells induced by Ag85B-TB10.4/IC31 against Mycobacterium tuberculosis is highly dependent on the antigen dose.
PLoS ONE
title Protection and polyfunctional T cells induced by Ag85B-TB10.4/IC31 against Mycobacterium tuberculosis is highly dependent on the antigen dose.
title_full Protection and polyfunctional T cells induced by Ag85B-TB10.4/IC31 against Mycobacterium tuberculosis is highly dependent on the antigen dose.
title_fullStr Protection and polyfunctional T cells induced by Ag85B-TB10.4/IC31 against Mycobacterium tuberculosis is highly dependent on the antigen dose.
title_full_unstemmed Protection and polyfunctional T cells induced by Ag85B-TB10.4/IC31 against Mycobacterium tuberculosis is highly dependent on the antigen dose.
title_short Protection and polyfunctional T cells induced by Ag85B-TB10.4/IC31 against Mycobacterium tuberculosis is highly dependent on the antigen dose.
title_sort protection and polyfunctional t cells induced by ag85b tb10 4 ic31 against mycobacterium tuberculosis is highly dependent on the antigen dose
url http://europepmc.org/articles/PMC2691953?pdf=render
work_keys_str_mv AT clausaagaard protectionandpolyfunctionaltcellsinducedbyag85btb104ic31againstmycobacteriumtuberculosisishighlydependentontheantigendose
AT tructhikimthanhhoang protectionandpolyfunctionaltcellsinducedbyag85btb104ic31againstmycobacteriumtuberculosisishighlydependentontheantigendose
AT angeloizzo protectionandpolyfunctionaltcellsinducedbyag85btb104ic31againstmycobacteriumtuberculosisishighlydependentontheantigendose
AT rolfbilleskov protectionandpolyfunctionaltcellsinducedbyag85btb104ic31againstmycobacteriumtuberculosisishighlydependentontheantigendose
AT jolynntroudt protectionandpolyfunctionaltcellsinducedbyag85btb104ic31againstmycobacteriumtuberculosisishighlydependentontheantigendose
AT kimarnett protectionandpolyfunctionaltcellsinducedbyag85btb104ic31againstmycobacteriumtuberculosisishighlydependentontheantigendose
AT andrewkeyser protectionandpolyfunctionaltcellsinducedbyag85btb104ic31againstmycobacteriumtuberculosisishighlydependentontheantigendose
AT taraelvang protectionandpolyfunctionaltcellsinducedbyag85btb104ic31againstmycobacteriumtuberculosisishighlydependentontheantigendose
AT peterandersen protectionandpolyfunctionaltcellsinducedbyag85btb104ic31againstmycobacteriumtuberculosisishighlydependentontheantigendose
AT jesdietrich protectionandpolyfunctionaltcellsinducedbyag85btb104ic31againstmycobacteriumtuberculosisishighlydependentontheantigendose